Merck boosts 2007 earnings forecast; shares rise
527030
Drugmaker Merck & Co. Inc.   boosted its 2007 earnings forecast on Wednesday, citing  higher-than-expected sales of multiple products, including its  cancer vaccine Gardasil and diabetes drug Januvia.
69797
Merck & Co.  on Wednesday stood  by its forecast of flat earnings for 2006 and projected  slightly higher 2007 results, in line with Wall Street  expectations, as the drugmaker grapples with generic  competition for a number of its medicines.
349051
Shares of drugmaker Merck & Co. Inc.  traded 1.52 percent higher on volume of more than 61,000 shares in pre-market dealings on Friday, a day after the stock plunged to an eight-year low after the company withdrew its arthritis drug Vioxx.
140665
Merck KGaA, the German drug and chemical company whose products include the multiple sclerosis drug Rebif and cancer treatment Erbitux, said Monday that its fourth-quarter profit soared to nearly $5 billion as it reaped the benefits of its acquisition of Serono and the divestiture of its generic drug unit.
404246
Stock indexes rose on Monday as deal news and pharmaceutical sector profits renewed optimism about the equities market after Friday's sell-off.
210616
Merck & Co. Inc., reeling from the recent withdrawal of its Vioxx arthritis drug, said Wednesday it expects 2005 earnings of &#36;2.42 to &#36;2.52 a share -- a decline from expected 2004 results.
427446
Monsanto Co.  said on Friday it is increasing its earnings outlook for fiscal 2007, due to strong results from the corn planting season in the U.S. and from the company's herbicide business.
299049
Eli Lilly and Co.  on Tuesday  posted better-than-expected second-quarter earnings helped by  surging sales of its prescription drugs, including depression  treatment Cymbalta, and the company raised its 2007 profit  forecast.
93237
Merck & Co. Inc. MRK.N, reeling from  the recent withdrawal of its Vioxx arthritis drug, on Wednesday  said 2005 earnings will decline to levels below Wall Street  expectations, the third straight year of lower results.
531122
German pharmaceutical giant Merck posted third quarter results Wednesday that exceeded analysts expectations, but the group said the strong euro would affect its full-year sales.
341429
Merck & Co.  on Monday said its  second-quarter earnings more than doubled on growing demand for  its drugs, blowing past Wall Street expectations, and raised  its full-year profit forecast.
29280
Stocks headed for a higher open on Monday as takeover news and stronger-than-expected profits in the pharmaceutical sector eased anxiety about earnings, which led to Friday's sell-off.
96706
U.S. stock indexes rose on Monday as takeover news and strong profits from blue-chip companies, including Merck & Co. , reassured investors after Friday's sell-off.
120706
Merck & Co  on Monday said its third-quarter profit rose sharply, helped by sales of its vaccines and cholesterol drugs, and raised its 2007 profit forecast in view of strong current trends.
34206
Merck & Co.  on Wednesday stood by its forecast of flat earnings for 2006 and projected slightly higher 2007 results, in line with Wall Street expectations, as the drugmaker grapples with generic competition for a number of its medicines.
134954
TORONTO (CP) - North American stock markets appear poised for strong gains Friday in the fourth quarter&#39;s first day of trading as investors recover from drug company Merck &amp; Co.
659061
KANSAS CITY, Missouri  - Monsanto Co  raised its 2007 earnings outlook on Monday, citing strong global corn sales, higher prices for its branded Roundup herbicides and a more favorable tax rate.